Pentazocine
Product Description
F.I.S. Fabbrica Italiana Sintetici S.p.A.
-
Country/Region:Italy
-
Founded:1957
-
On CPHI since:2015
-
Certificates:3
-
Employees:1000 - 4999
Company types
Primary activities
F.I.S. Fabbrica Italiana Sintetici S.p.A.
-
Country/Region:Italy
-
Founded:1957
-
On CPHI since:2015
-
Certificates:3
-
Employees:1000 - 4999
Company types
Primary activities
More Products from F.I.S. Fabbrica Italiana Sintetici S.p.A. (26)
-
Product Indomethacin
FIS produces a wide range of API's which includes Indomethacin. It is commercially available. Contact us for more information. -
Product Ketazolam
FIS produces a wide range of API's which includes Ketazolam. It is commercially available. Contact us for more information. -
Product Midazolam
FIS produces a wide range of API's which includes Midazolam. It is commercially available. Contact us for more information. -
Product Nitrazepam
FIS produces a wide range of API's which includes Nitrazepam. It is commercially available. Contact us for more information. -
Product Olopatadine Hydrochloride
FIS produces a wide range of API's which includes Olopatadine Hydrochloride. It is commercially available. Contact us for more information. -
Product Oxazepam
FIS produces a wide range of API's which includes Oxazepam. It is commercially available. Contact us for more information. -
Product Prazepam
FIS produces a wide range of API's which includes Prazepam. It is commercially available. Contact us for more information. -
Product Quetiapine Fumarate
FIS produces a wide range of API's which includes Quetiapine Fumarate. It is commercially available. Contact us for more information. -
Product Progesterone
FIS produces a wide range of API's which includes Progesterone. It is commercially available. Contact us for more information. -
Product Temazepam
FIS produces a wide range of API's which includes Temazepam. It is commercially available. Contact us for more information. -
Product Nitrofurantoin macrocrustals and monohydrate
FIS produces a wide range of API's which includes Nitrofurantoin macrocrystals and monohydrate. It is commercially available. Contact us for more information:[email protected]
F.I.S. Fabbrica Italiana Sintetici S.p.A. resources (3)
-
News Revenues up 20% in 2022
The growth trend remains in the first quarter of 2023: revenues of €153 million, up 31% compared to the first quarter of 2022 -
News FIS joins Energize
Energize is the international programme discussed at COP27 that aims to promote the use of renewable energy and to reduce greenhouse gas emissions in the chemical and pharmaceutical sector. -
News FIS redefines the structure of its commercial department
Luca Parlanti and Gianluca Schiavoni join FIS as directors of the new generics and custom divisions

